EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Defense DEF

Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill

Contacted: Federal Trade Commission (FTC); Health Resources & Services Administration (HRSA); SENATE; Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Congressional Budget Office (CBO); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Office of Personnel Management (OPM); White House Office; Internal Revenue Service (IRS)

Taxation/Internal Revenue Code TAX

Regulatory implementation of various tax provisions in the health reform legislation

Contacted: Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Congressional Budget Office (CBO); Office of Personnel Management (OPM); Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); SENATE; Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); White House Office

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General reg/leg Part D issues such as direct negotiation (budget proposals). Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors' prompt pay discounts from the definition of Average Sales Price. Medicare regulatory/legislative proposals to impede audit, mail order and preferred network restrictions.S. 867, Medicare Prescription Drug Integrity and And Transparency Act of 2013. General issues and legislation (HR 3392) regarding combatting Rx abuse in Medicare and Medicaid (pharmacy lock-in, etc). Issues regarding Maximum Allowable Cost (HR 4437)

Contacted: Labor, Dept of (DOL); Medicare Payment Advisory Commission (MedPAC); Internal Revenue Service (IRS); Food & Drug Administration (FDA); Congressional Budget Office (CBO); Office of Personnel Management (OPM); SENATE; Health Resources & Services Administration (HRSA); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Federal Trade Commission (FTC); White House Office; HOUSE OF REPRESENTATIVES

Bills named: S. 867 (113th), H.R. 4437 (113th), H.R. 3392 (113th)

Pharmacy PHA

Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit design and pricing (MAC)issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.

Contacted: Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Office of Personnel Management (OPM); Federal Trade Commission (FTC); White House Office; Internal Revenue Service (IRS); SENATE; Food & Drug Administration (FDA); Government Accountability Office (GAO); Labor, Dept of (DOL); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA)

Bills named: H.R. 3392 (113th), S. 867 (113th), H.R. 1367 (113th)

Health Issues HCR

Regulatory policies related to health reform legislation: structure, drug benefits, disclosure Regulatory implementation of HITECH/Accounting of Disclosures Issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs).

Contacted: HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Internal Revenue Service (IRS); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); White House Office; Food & Drug Administration (FDA); SENATE; Federal Trade Commission (FTC); Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS)

Postal POS

Postal Reform proposals and their impact on 6 day mail delivery

Contacted: Medicare Payment Advisory Commission (MedPAC); White House Office; Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); Office of Personnel Management (OPM); SENATE; Government Accountability Office (GAO); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Federal Trade Commission (FTC)

Labor Issues/Antitrust/Workplace LBR

Legislation to exempt certain pharmacies from the antitrust laws for purposes of negotiating with payers (HR 1188)

Contacted: Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); White House Office; Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); Federal Trade Commission (FTC); Labor, Dept of (DOL); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); Congressional Budget Office (CBO); SENATE

Bills named: H.R. 1188 (113th)